García M/ Enfermería Investiga Vol. 9 No. 2 2024 (April – June)
75
be excluded from the diagnosis of Persistent
COVID. In the Health Surveillance Unit of the
EDPSSJRBC Prevention Service, a medical
procedure was implemented for the detection,
assistance and monitoring of workers with
Persistent COVID symptoms.
The continuity of Persistent COVID symptoms, apart
from the possible impact on workers' daily activities,
may have an implication on the development of their
work activity, with the need for temporary or
permanent work disability or adaptations to their job,
to be assessed by the Health Surveillance Services
(7-9).
The purpose of this study is to record the symptoms
presented by the workers at the Sant Joan de Reus
Hospital and Primary Care of Reus and Baix Camp,
the healthcare, rehabilitation and follow-up care
provided to the workers in the period from March
2020 to November 2022. Since the study has been
carried out within the framework of the Health
Surveillance Unit, the work impact of the workers
derived from Persistent COVID and the need for
functional adaptation that they may have required in
their work place has also been assessed during the
study period.
METHODS
This is an observational, descriptive study of the
workers of the EDPSSJBC company, in September
2022, who suffered from COVID-19 and the
symptoms of Persistent COVID developed in the
period 2020 to 2022. The workers who were
excluded: not belonging to EDPSSJBC; workers in
a situation of incapacity for work and those who did
not complete all phases of the study.
To evaluate the Persistent COVID clinic from the
Health Surveillance Unit of the Occupational Risk
Prevention Service, the Procedure for care action in
workers with Persistent COVID (2021), in force at
EDPSSBC, was applied.
This procedure consists of: sending a survey of
symptoms compatible with Persistent COVID
(Fever, low-grade fever or chills, fatigue that
prevents daily activity, myalgia at rest or daily
activity, arthralgia of extremities at rest, dyspnea at
rest or daily activities, persistent cough, chest pain
at rest or daily activity, anosmia or ageusia,
headache, diarrhea, memory loss, changes in
mood, sadness, crying, nervousness, insomnia,
alopecia) to workers who had suffered from COVID-
19. Those who responded affirmatively to Persistent
symptoms of more than 12 weeks were scheduled
to undergo a health examination. This health
examination included a nursing part with the
completion of a new Persistent COVID symptoms
questionnaire at the time of the visit, application of
different tests and scales, all with validity and
reliability (10,11).
These scales include: EQ5D functional quality of life
scales (EuroQol) (Cronbach 0.75) (12.13), mMRC
Test for evaluation of dyspnea (Pearson coef 0.92)
(14.15), Test Hamilton anxiety/depression scale
(HAD) (Cronbach 0.89) (16.17), Post COVID-19
Functional Status Scale (PCFS) ((kappa 0.63))
(18.19), Modified Impact of Fatigue (MFIS)
(Cronbach 0.81) (20.21), Sleep Scale: Insomnia
Severity Index (Cronbach 0.82) (22.23), Pain
Assessment Questionnaire (Bpi) (Cronbach 0.82)
76) (24.25) and Montreal Cognitive Assessment
(MOCA) (Cronbach's 0.891) (26.27). In addition, the
specific analytical determination was carried out:
total SARS CoV-2 antibodies (Ab), blood count,
ESR, albumin, total and direct bilirubin, serum
calcium, total cholesterol and cholesterol fractions,
complement CH50, C3, C4, creatinine, glomerular
filtration rate , rheumatoid factor, ferritin, iron, folate,
alkaline phosphatase, phosphorus, GGT, GOT,
GPT, glucose, glycosylated hemoglobin, ionogram
(sodium and potassium), C-reactive protein, total
proteins, transferrin, triglycerides, urea, vitamin B12,
vitamin D, antithrombin III, prothrombin time,
activated partial thromboplastin, antinuclear
antibodies, DNA autoantibodies, TSH, T3 and T4,
apoprotein, creatine kinase, fibrinogen, lactic
dehydrogenase, and antiphospholipid syndrome.
Anthropometric data were recorded: weight, height
and abdominal circumference. Measurement of
blood pressure, pulse, oxygen saturation, body
temperature was carried out. And a spirometry and
an electrocardiogram were performed.
Subsequently, it was scheduled for the medical
health examination to: evaluate the data collected by
the nursing staff, the analytical results and the tests
performed, as well as the tests completed by the
workers. A clinical history was taken: directed
anamnesis of the COVID-19 disease (onset,
symptoms, treatment performed, hospital/ICU
admissions, mechanical ventilation requirements...),
anamnesis of previous history, chronic treatments
and assessment of Persistent COVID symptoms. A
directed physical examination was performed:
neurological examination (cranial nerves,
coordination and balance tests, Romberg test...),
cardiorespiratory, oropharyngeal and abdominal
examination, lumbar fist percussion,
musculoskeletal examination, eye examination,
otoscopy, skin examination; assessment of the need
for treatment. Complementary tests were requested:
Chest radiology or lung CT, respiratory functional
tests, echocardiogram... or referrals to other medical
specialties: Sports Medicine and/or Physiotherapy
Unit, Cognitive Impairment Unit, Medicine Unit
Internal, Otorhinolaryngology Unit, Cardiology Unit,
Digestology Unit, Rheumatology Unit, Dermatology
Unit...
Subsequent follow-up visits were made to the
workers who required it with an in-person or
telephone appointment to evaluate the results of the
complementary tests requested, treatments
performed, consultations with other medical
specialties requested and/or relevant referrals to
other Hospital services. as well as assessment of
the health status of the professional.
The results of the workers who presented symptoms
of Persistent COVID and who participated in the
study of the EDPSSBC Health Surveillance Unit
were analyzed. The variables considered were: age,